Equity · Healthcare
KALV
NGMKalVista Pharmaceuticals Inc
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for KALV to draw a line in its place.
KALV insider trades
KALV has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 11 June 2026.
Showing the 12 most recent of 40 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 57 compensation filings in this window. The figures above count all of them.
KALV earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
KALV institutional holders
SEC EDGAR0 of the 45 institutional funds we track reported a KALV position for the quarter ended 30 Jun 2026; the latest of those filings landed 02 Sep 2026.
Congressional trades in KALV
House disclosuresThe most recent congressional trade disclosed in KALV is a purchase by Sara Jacobs (house, CA), dated 12 Dec 2022.
Sources
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR 13F filings
- House disclosuresU.S. House of Representatives financial disclosures